AXA’s Linden Thomson: You need a scientific background to be a biotech investor
March 1, 202331m 7s
Audio is streamed directly from the publisher (dl.iono.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Linden Thomson, manager of the Axa Framlington Biotech fund, speaks about the 'heavily momentum driven' biotech sector, and why Biden’s inflation reduction act could tighten R&D investment.